George Paul V, Hooda Amit, Pati Purinder K, Varghese Lijo, Lahiri Anandroop
Professor, Department of Cardiology, Christian Medical College Hospital, Vellore 632004, Tamil Nadu, India.
Assistant Professor, Department of Cardiology, Christian Medical College Hospital, Vellore 632004, Tamil Nadu, India.
Indian Heart J. 2014 Sep-Oct;66(5):503-5. doi: 10.1016/j.ihj.2014.08.001. Epub 2014 Aug 28.
Coronary artery disease is the leading cause of mortality and morbidity in our country, of which ST elevation myocardial infarction (STEMI) accounts for the major part of health spending. We sought to study the effect of induction of government health insurance scheme on the trends of reperfusion in patients of acute STEMI.
1133 patients presenting with acute STEMI enrolled. 1079 (95.1%) received some form of reperfusion therapy. Primary PCI was used in 60.6% of patients as the primary reperfusion modality, a six fold increase as compared to previous years. Government health insurance accounted for the one third of all. 34.5% patients underwent pharmacological reperfusion, most commonly with streptokinase. 4.9% patients of STEMI did not receive any form of reperfusion therapy in contrast to 14% during previous years.
Introduction of government health insurance along with increased awareness has resulted in dramatic changes in the management of STEMI patients.
冠心病是我国死亡和发病的主要原因，其中ST段抬高型心肌梗死（STEMI）占医疗支出的主要部分。我们试图研究政府医疗保险计划的实施对急性STEMI患者再灌注趋势的影响。
纳入1133例急性STEMI患者。1079例（95.1%）接受了某种形式的再灌注治疗。60.6%的患者采用直接经皮冠状动脉介入治疗（Primary PCI）作为主要再灌注方式，与前几年相比增加了六倍。政府医疗保险占所有费用的三分之一。34.5%的患者接受了药物再灌注治疗，最常用的是链激酶。4.9%的STEMI患者未接受任何形式的再灌注治疗，而前几年这一比例为14%。
政府医疗保险的引入以及意识的提高导致了STEMI患者管理的巨大变化。
